Bartolo Colon Getty

Columnist calls for enhanced drug testing, chooses to discredit results of drug testing


Christine Brennan’s latest column for USA Today decries the fact that Bartolo Colon is in the All-Star Game. Why? Because he tested positive for PEDs last year:

Colon, and every other performance-enhancing drug user in baseball, should never be allowed to become an All-Star, or win any MLB award. No Cy Young, no MVP, no batting title, no nothing. It doesn’t matter that he was caught and suspended last year, not this year. (Although with the reported Biogenesis suspensions still looming, the year is young.) The bottom line is, you don’t suddenly become a non-cheater once your suspension is over.

It’s her right to believe that someone who cheats once must always be cheating, regardless of what the drug tests say. But it is curious coming from Brennan, because for at least six years now her PED hobby horse has been all about getting Major League Baseball to adopt the USADA’s drug testing regime. How one can call for enhanced testing while simultaneously dismissing the results of drug testing (and while failing to point out how MLB’s drug testing program is lacking) is a neat trick, but I guess I can’t understand it given that I’m not a trained journalist living in a major city.

But the worst part of this column is how it completely misrepresents the role of the union with respect to baseball’s drug problem. Brennan says:

Because as much as MLB’s leaders try to clean up their game, the players’ union lags years behind, fighting harder for the cheaters than it does for the players the cheaters shove off All-Star teams and awards dinner stages, and out of record books … Why the players’ union doesn’t speak out for people like [Matt] Moore is mystifying. It will fight harder for Colon and his alleged Biogenesis buddies — Nelson Cruz, Jhonny Peralta, Everth Cabrera, Ryan Braun, Alex Rodriguez, et. al. — than it ever will for the poor non-cheating players who continue to quietly accept their fate.

She may have had a point a decade ago when the union was still hostile to drug testing, but she’s completely ignoring current reality. On multiple occasions over the past several years the union has agreed to stiffer drug testing penalties and enhanced testing. Indeed, just this past winter they ratcheted things up significantly adding unannounced HGH testing and testosterone baseline tests, the likes of which Brennan herself has long called for. That baseline testing, by the way, is being supervised by the WADA, which Brennan said in 2007 must get involved and which she herself considered to be the gold standard of anti-doping efforts. Moving goalposts is hard work, of course, so maybe she was just distracted and forgot that she wrote that column.

She is also ignoring the fact that every public statement the union makes on drug matters acknowledges the importance of the drug testing program. And that players and the union have repeatedly and increasingly given voice to their desire for a clean game and the protection of players who do not use performance enhancing drugs.

All of that would get in the way of a good, outraged column, of course. So I totally understand why she ignores it.

Mariners interested in free agent outfielder Nori Aoki

AP Photo/Ben Margot
Leave a comment

New Mariners general manager Jerry Dipoto has kept pretty busy in his short time on the job and Bob Dutton of the Tacoma News Tribune reports that free agent outfielder Nori Aoki could be his next target. The club recently pursued a trade for Marlins outfielder Marcell Ozuna, but the asking price has them looking at alternatives.

Aoki, who turns 34 in January, has hit .287 with a .353 on-base percentage over four seasons since coming over from Japan. He was having a fine season with the Giants this year prior to being shut down in September with lingering concussion symptoms.

The Giants decided against picking up Aoki’s $5.5 million club option for 2016 earlier this month, but he should still do pretty well for himself this winter assuming he’s feeling good.

Report: Johnny Cueto is believed to be looking for a $140-160 million deal

AP Photo/Matt Slocum
Leave a comment

It was reported Sunday that free agent right-hander Johnny Cueto had turned down a six-year, $120 million contract from the Diamondbacks. He’s hoping to land a bigger deal this winter and ESPN’s Jerry Crasnick has heard some chatter about what he’s looking for.

Jordan Zimmermann finalized a five-year, $110 million contract with the Tigers today, which works out to $22 million per season. Arizona’s offer to Cueto checked in at $20 million per season. A six-year offer to Cueto at the same AAV (average annual value) as Zimmermann would put him at $132 million, which is still a little shy of the figure stated by Crasnick. Of course, Cueto owns a 2.71 ERA (145 ERA+) over the last five seasons compared to a 3.14 ERA (123 ERA+) by Zimmermann during that same timespan, so there’s a case to be made that he should get more. Still, he’s the clear No. 3 starter on the market behind David Price and Zack Greinke.

CBS Sports’ Jon Heyman reports that the Dodgers, Giants, Red Sox, and Cubs are among the other teams who have interest in Cueto. One variable in his favor is that he is not attached to draft pick compensation, as he was traded from the Reds to the Royals during the 2015 season.

Report: Around 20 teams have contacted the Braves about Shelby Miller

AP Photo/John Bazemore
Leave a comment

The rebuilding Braves have already been active on the trade market and they might not be done, as CBS Sports’ Jon Heyman reports that right-hander Shelby Miller has been a very popular name. In fact, around 20 teams have checked in.

Nothing is considered close and the Braves have set a very high asking price, mostly centered around offense. They asked for right-hander Luis Severino in talks with the Yankees and would expect outfielder Marcell Ozuna among other pieces from the Marlins. The Diamondbacks and Giants are among the other interested clubs.

Miller is under team control through 2018, so there’s not necessarily a sense of urgency to move him, but anything is possible with the way the Braves are doing things right now. The 25-year-old is coming off a year where he went 6-17, but that was about really rotten luck more than anything else, as he had a fine 3.02 ERA and 171/73 K/BB ratio over 205 1/3 innings. The Braves gave him the worst run support of any starter in the majors.

Mets expected to tender a contract to Jenrry Mejia

NEW YORK, NY - JULY 12:  Jenrry Mejia #58 of the New York Mets reacts as he walks off the field after getting the final out of the seventh inning against the Arizona Diamondbacks at Citi Field on July 12, 2015 in the Flushing neighborhood of the Queens borough of New York City.  (Photo by Jim McIsaac/Getty Images)
Photo by Jim McIsaac/Getty Images

Jenrry Mejia appeared in just seven games this past season due to a pair of suspensions for performance-enhancing drugs, but Adam Rubin of ESPN New York reports that the Mets are expected to tender him a contract for 2016.

While the Mets were vocal about their disappointment in Mejia’s actions, it makes sense to keep him around as an option. Had he played a full season in 2015, he would have earned $2.595 million. He’s arbitration-eligible for the second time this winter and figures to receive a contract similar to his 2015 figure, but he’ll only be paid for the games he plays. He still has 100 games to serve on his second PED suspension, which means that he’ll only be paid for 62 games in 2016. This likely puts his salary closer to $1 million, which is a small price to pay for someone who could prove useful during the second half and beyond. He also won’t count toward the team’s 40-man roster until he’s active.

Mejia, who turned 26 in October, owns a 3.68 ERA in the majors and saved 28 games for the Mets in 2014. He’s currently pitching as a starter in the Dominican Winter League.